Literature DB >> 8033924

Chronic fatigue: a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents.

R Priori1, F Conti, F L Luan, C Arpino, G Valesini.   

Abstract

We describe four Italian adolescents in whom a persistent, debilitating fatigue appeared after therapeutic ingestion of products containing L-tryptophan and subsequent to the development of a transient rise in eosinophil count and severe myalgia (Eosinophilia Myalgia Syndrome-EMS). Their clinical picture was indistinguishable from that of the so-called Chronic Fatigue Syndrome. A chronic fatigue may occur after diverse triggering agents and its represents the peculiar clinical evolution of these four paediatric cases of EMS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033924     DOI: 10.1007/bf01956416

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome.

Authors:  A N Mayeno; F Lin; C S Foote; D A Loegering; M M Ames; C W Hedberg; G J Gleich
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

2.  Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases.

Authors:  K M Bell; D Cookfair; D S Bell; P Reese; L Cooper
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

3.  Chronic fatigue syndrome: a working case definition.

Authors:  G P Holmes; J E Kaplan; N M Gantz; A L Komaroff; L B Schonberger; S E Straus; J F Jones; R E Dubois; C Cunningham-Rundles; S Pahwa
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

Review 4.  The cause and pathogenesis of the eosinophilia-myalgia syndrome.

Authors:  J Varga; J Uitto; S A Jimenez
Journal:  Ann Intern Med       Date:  1992-01-15       Impact factor: 25.391

5.  Eosinophilia-myalgia syndrome--New Mexico.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-11-17       Impact factor: 17.586

6.  Psychosocial management of chronic fatigue syndrome in adolescence.

Authors:  C J Rikard-Bell; B G Waters
Journal:  Aust N Z J Psychiatry       Date:  1992-03       Impact factor: 5.744

7.  Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome.

Authors:  A M Bakheit; P O Behan; T G Dinan; C E Gray; V O'Keane
Journal:  BMJ       Date:  1992-04-18

8.  Natural history of the eosinophilia-myalgia syndrome.

Authors:  R C Culpepper; R G Williams; P J Mease; T D Koepsell; J M Kobayashi
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

Review 9.  L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis.

Authors:  J Varga; S A Jimenez; J Uitto
Journal:  J Invest Dermatol       Date:  1993-01       Impact factor: 8.551

10.  Antinuclear autoantibodies in women with silicone breast implants.

Authors:  R I Press; C L Peebles; Y Kumagai; R L Ochs; E M Tan
Journal:  Lancet       Date:  1992-11-28       Impact factor: 79.321

  10 in total
  1 in total

1.  Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome.

Authors:  K Konstantinov; A von Mikecz; D Buchwald; J Jones; L Gerace; E M Tan
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.